"We offer a comprehensive team approach to your healthcare needs. Internal medicine with you in the forefront."

During the past decade, Arrowhead Internal Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Arrowhead Internal Medicine" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Arrowhead Internal Medicine" in a lesser frequency.

Most popular intervention types in "Arrowhead Internal Medicine" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arrowhead Internal Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Arrowhead Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Arrowhead Internal Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arrowhead Internal Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".